At Texas Retina Associates, our physicians remain actively involved in conducting research that will improve care for our patients, offering access to promising new retinal treatments through clinical trials. We recently opened seven new studies:
Diabetic Retinopathy
– DRCR Study Protocol AF, Lubbock
Dry Macular Degeneration with Geographic Atrophy
– Parasol, Dallas Main & Fort Worth
– SIGLEC, Dallas Main
Retinal Vein Occlusion
– Quasar 22153, Fort Worth
– Rivoli BP 44241, Arlington
Uveitis
– Leopard, Plano
Wet Macular Degeneration
– Odyssey, Plano
Click here for additional details about these new clinical trials as well as 23 others we are currently offering for a variety of retina conditions.